title: The MASCC Neutropenia, Infection and Myelosuppression Study Group evaluates recent new concepts for the use of granulocyte colony-stimulating factors for the prevention of febrile neutropenia.
authors.affiliation: Institut Jules Bordet, Centre des Tumeurs de l'Université Libre de Bruxelles, Brussels, Belgium. jean.klastersky@scm-sprl.net
authors.forename: Jean
authors.initials: J
authors.lastname: Klastersky
authors.forename: Harry
authors.initials: H
authors.lastname: Raftopoulos
authors.forename: Bernardo
authors.initials: B
authors.lastname: Rapoport
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D064147:Febrile Neutropenia / Q000139:chemically induced / Q000188:drug therapy / Q000517:prevention & control*; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D009504:Neutrophils / Q000187:drug effects / Q000276:immunology; D009894:Opportunistic Infections / Q000276:immunology / Q000517:prevention & control*
chemical_list: D000970:Antineoplastic Agents; D016179:Granulocyte Colony-Stimulating Factor